Study of Combivir for Patients With Primary Biliary Cirrhosis
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Andrew L Mason, MBBS MRCPI
University of Alberta
Principal Investigator - Bruce Bacon, MD
St. Louis University
Principal Investigator - Catherine Vincent, MD FRCPC
Université de Montréal
Principal Investigator - James Neuberger, MD FRCP
University of Birmingham
Principal Investigator - Keith Lindor, MD
Mayo Clinic Foundation
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alberta
Edmonton, Alberta, Canada
- University of Montreal
Montreal, Quebec, Canada
- University of Birmingham
Birmingham, England, United Kingdom
- Mayo Clinic
Rochester, Minnesota, United States
- St Louis University
St Louis, Missouri, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2004
- Primary completion
- —
- Completion
- 30 Apr 2007
- Last update posted
- 1 Nov 2007
- Registered enrollment
- 59
- Registry id
- NCT00490620
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.